Product
CLBS12
1 clinical trial
4 indications
Indication
Critical Limb IschemiaIndication
Thromboangiitis obliteransIndication
Thromboangiitis ObliteransIndication
Atherosclerosis ObliteransClinical trial
A Prospective, Open Label, Controlled, Randomized, Multicenter Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI) Due to Arteriosclerosis Obliterans (ASO) With a Single-arm Substudy to Assess the Safety and Potential Efficacy of CLBS12 in Patients With CLI Due to Buerger's Disease (BD)Status: Completed, Estimated PCD: 2022-05-19